Literature DB >> 2445121

Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins.

B Dietzschold1, M Lafon, H Wang, L Otvos, E Celis, W H Wunner, H Koprowski.   

Abstract

To locate epitopes on internal antigens of rabies virus, purified N and NS proteins of the nucleocapsid were cleaved at methionine, tryptophan or glutamic acid residues, transferred to nitrocellulose and immunostained using monoclonal antibodies (MAbs) specific for N and NS proteins, respectively. Five MAb-positive fragments of N protein and one fragment of NS protein were located after NH2-terminal amino acid sequence analysis within the deduced amino acid sequences of N and NS proteins. Antigenic analysis of synthetic overlapping peptides corresponding to the amino acid sequences of these fragments localized two major antigenic sites of N protein and one antigenic site of NS protein. Like the N- and NS-specific MAbs, anti-peptide antisera produced against the different synthetic antigens either reacted in a type-common fashion with all rabies virus strains, or in a type-specific manner with a restricted number of strains. The synthetic peptides corresponding to the three antigenic regions of the N and NS proteins also stimulated proliferation of human T lymphocytes derived from vaccinees who received inactivated rabies virus vaccine. This suggested that the antigenic regions of N and NS proteins are recognized by both B and T cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445121     DOI: 10.1016/0168-1702(87)90023-2

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  22 in total

1.  Conserved nucleotide sequence of rabies virus cDNA encoding the nucleoprotein.

Authors:  K Mannen; K Hiramatsu; K Mifune; S Sakamoto
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

2.  Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Authors:  B Dietzschold; M Gore; D Marchadier; H S Niu; H M Bunschoten; L Otvos; W H Wunner; H C Ertl; A D Osterhaus; H Koprowski
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells.

Authors:  J K Larson; W H Wunner; L Otvos; H C Ertl
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Nucleocapsid of rabies virus improve immune response of an inactivated avian influenza vaccine.

Authors:  Elizabeth Loza-Rubio; Juan Molina-Güarneros; Juan Antonio Montaño-Hirose
Journal:  Vet Res Commun       Date:  2009-01-31       Impact factor: 2.459

5.  The free nucleocapsids of the viral haemorrhagic septicaemia virus contain two antigenically related nucleoproteins.

Authors:  B Basurco; F Sanz; M A Marcotegui; J M Coll
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor, P.

Authors:  Todd J Green; Ming Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

Review 7.  Superantigen related to rabies.

Authors:  M Lafon; A Galelli
Journal:  Springer Semin Immunopathol       Date:  1996

8.  Conserved characteristics of the rhabdovirus nucleoprotein.

Authors:  Ming Luo; Todd J Green; Xin Zhang; Jun Tsao; Shihong Qiu
Journal:  Virus Res       Date:  2007-08-30       Impact factor: 3.303

9.  Expression of the nucleoprotein of rabies virus in Escherichia coli and mapping of antigenic sites.

Authors:  H Goto; N Minamoto; H Ito; T R Luo; M Sugiyama; T Kinjo; A Kawai
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Molecular characterization of KGH, the first human isolate of rabies virus in Korea.

Authors:  Jun-Sun Park; Chi-Kyeong Kim; Su Yeon Kim; Young Ran Ju
Journal:  Virus Genes       Date:  2012-12-15       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.